Splenic Infarction as the Initial Manifestation of Antiphospholipid Syndrome in a Systemic Lupus Erythematosus Patient / 대한내과학회지
Korean Journal of Medicine
;
: 651-654, 2014.
Article
in Korean
| WPRIM
| ID: wpr-151946
ABSTRACT
Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease. In patients with SLE, the prevalence of antiphospholipid antibodies is considerably higher, and is largely responsible for thrombosis. Splenic infarction is a rare complication of arterial thrombosis in patients with SLE. It is important to consider splenic infarction in a patient with SLE complaining of left upper quadrant (LUQ) pain because of the possibility of severe infarction-related complications, such as subcapsular hemorrhage and splenic rupture. We report a case of solitary splenic infarction in a patient with SLE. The only symptom was LUQ pain of 3-day duration. Lupus anticoagulant activity was positive and abdominal-pelvic computed tomography (CT) was consistent with splenic infarction. She did not show any other evidence of thrombotic events. The patient was diagnosed with antiphospholipid syndrome that presented as a splenic infarction in a SLE patient.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Autoimmune Diseases
/
Splenic Infarction
/
Splenic Rupture
/
Thrombosis
/
Prevalence
/
Lupus Coagulation Inhibitor
/
Antiphospholipid Syndrome
/
Antibodies, Antiphospholipid
/
Hemorrhage
/
Lupus Erythematosus, Systemic
Type of study:
Prevalence study
Limits:
Humans
Language:
Korean
Journal:
Korean Journal of Medicine
Year:
2014
Type:
Article
Similar
MEDLINE
...
LILACS
LIS